vs
Side-by-side financial comparison of Applied Therapeutics, Inc. (APLT) and T Stamp Inc (IDAI). Click either name above to swap in a different company.
Applied Therapeutics, Inc. is the larger business by last-quarter revenue ($1.0M vs $908.9K, roughly 1.1× T Stamp Inc). T Stamp Inc runs the higher net margin — -279.9% vs -1899.0%, a 1619.1% gap on every dollar of revenue. On growth, Applied Therapeutics, Inc. posted the faster year-over-year revenue change (719.7% vs -39.3%).
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG (RFLB.S) and listed on the SIX Swiss Exchange in 2016.
T Stamp Inc, trading under ticker IDAI, develops AI-powered identity verification, trust scoring, and fraud prevention solutions. It serves clients across fintech, healthcare, and e-commerce segments, primarily operating in North America to help organizations securely authenticate user identities and mitigate fraud risks.
APLT vs IDAI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0M | $908.9K |
| Net Profit | $-19.0M | $-2.5M |
| Gross Margin | — | — |
| Operating Margin | -1675.8% | -224.9% |
| Net Margin | -1899.0% | -279.9% |
| Revenue YoY | 719.7% | -39.3% |
| Net Profit YoY | 72.3% | 57.7% |
| EPS (diluted) | $-0.13 | $-0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $908.9K | ||
| Q3 25 | $1.0M | $872.5K | ||
| Q2 25 | $0 | $812.7K | ||
| Q1 25 | $0 | $545.5K | ||
| Q4 24 | $-1.0K | $1.5M | ||
| Q3 24 | — | $511.1K | ||
| Q2 24 | $144.0K | $500.4K | ||
| Q1 24 | $190.0K | $573.7K |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-19.0M | $-1.9M | ||
| Q2 25 | $-21.3M | $-1.7M | ||
| Q1 25 | $-21.8M | $-2.2M | ||
| Q4 24 | $44.0M | $-6.0M | ||
| Q3 24 | — | $-1.3M | ||
| Q2 24 | $2.9M | $-2.6M | ||
| Q1 24 | $-83.9M | $-2.7M |
| Q4 25 | — | -224.9% | ||
| Q3 25 | -1675.8% | -203.0% | ||
| Q2 25 | — | -207.0% | ||
| Q1 25 | — | -396.5% | ||
| Q4 24 | 3302300.0% | -81.2% | ||
| Q3 24 | — | -523.7% | ||
| Q2 24 | -14194.4% | -524.7% | ||
| Q1 24 | -11101.6% | -496.7% |
| Q4 25 | — | -279.9% | ||
| Q3 25 | -1899.0% | -219.1% | ||
| Q2 25 | — | -210.7% | ||
| Q1 25 | — | -395.5% | ||
| Q4 24 | -4400700.0% | -401.5% | ||
| Q3 24 | — | -245.7% | ||
| Q2 24 | 2012.5% | -519.3% | ||
| Q1 24 | -44177.9% | -466.9% |
| Q4 25 | — | $-0.37 | ||
| Q3 25 | $-0.13 | $-0.72 | ||
| Q2 25 | $-0.15 | $-0.69 | ||
| Q1 25 | $-0.15 | $-0.89 | ||
| Q4 24 | $0.52 | $-3.14 | ||
| Q3 24 | — | $-1.06 | ||
| Q2 24 | $-0.13 | $-3.19 | ||
| Q1 24 | $-0.67 | $-3.97 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.9M | $6.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-561.0K | $8.7M |
| Total Assets | $34.4M | $11.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.0M | ||
| Q3 25 | $11.9M | $5.4M | ||
| Q2 25 | $30.4M | $292.1K | ||
| Q1 25 | $50.8M | $1.1M | ||
| Q4 24 | $79.4M | $2.8M | ||
| Q3 24 | — | $598.0K | ||
| Q2 24 | $122.2M | $659.5K | ||
| Q1 24 | $146.5M | $816.7K |
| Q4 25 | — | $8.7M | ||
| Q3 25 | $-561.0K | $6.1M | ||
| Q2 25 | $17.4M | $2.4M | ||
| Q1 25 | $36.7M | $4.1M | ||
| Q4 24 | $57.0M | $3.0M | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | $72.4M | $750.4K | ||
| Q1 24 | $67.3M | $1.4M |
| Q4 25 | — | $11.2M | ||
| Q3 25 | $34.4M | $11.2M | ||
| Q2 25 | $37.3M | $5.7M | ||
| Q1 25 | $56.9M | $6.6M | ||
| Q4 24 | $86.7M | $8.6M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | $127.8M | $5.2M | ||
| Q1 24 | $151.2M | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.4M | $2.0M |
| Free Cash FlowOCF − Capex | — | $2.0M |
| FCF MarginFCF / Revenue | — | 215.4% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-18.4M | $-4.0M | ||
| Q2 25 | $-20.3M | $-2.1M | ||
| Q1 25 | $-28.6M | $-1.5M | ||
| Q4 24 | $-19.5M | $-2.7M | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | $-22.6M | $-1.6M | ||
| Q1 24 | $-18.9M | $-2.2M |
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $-4.0M | ||
| Q2 25 | — | $-2.1M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-2.2M |
| Q4 25 | — | 215.4% | ||
| Q3 25 | — | -459.6% | ||
| Q2 25 | — | -258.6% | ||
| Q1 25 | — | -289.2% | ||
| Q4 24 | — | -182.9% | ||
| Q3 24 | — | -475.4% | ||
| Q2 24 | — | -320.9% | ||
| Q1 24 | — | -376.6% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.44× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -7.80× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
